Survival and end-stage renal disease rates in patients with lupus nephritis (LN) have not changed significantly in the past 30 years, UK figures show. According to lead author Professor David Isenberg from the UCL Centre for Rheumatology in London and colleagues, the findings ‘strongly’ suggest that the use of conventional immunosuppressives and steroids has been ...
Mortality rates in lupus nephritis haven’t improved in three decades
By Nicola Garrett
3 Nov 2020